News
Oral JAK inhibitor for alopecia areata advances to phase 3
CTP-543, a selective JAK1/2 inhibitor, aims to fill unmet need.
News
Why a mycosis fungoides diagnosis takes so long
“Judicious use of molecular studies may help in establishing the diagnosis, but I don’t think any one molecular study is ever going to be our home...
News
Home phototherapy never looked better, expert says
Safety and efficacy of home narrow-band UVB phototherapy match office-based UVB, but with greater patient convenience.
News
Acute-on-chronic itch is new frontier in atopic dermatitis
Research attention is focusing on role of circulating IgE-activated basophils.
News
Novel topical acne combo hits marks in phase 3 trials
The fixed-dose combination of benzoyl peroxide and tretinoin is under FDA review.
News
Daily sunscreen use will prevent more melanoma deaths than early detection
“Prevention is low cost, low risk, and effective.”
News
International expert group agrees on redefining psoriasis severity
“What we came up with is a very sensible approach to defining whether patients should get either topical or systemic therapy.”
News
The case for anti–IL-17 agents as first-line biologics in psoriatic arthritis
“The guidelines don’t give full credit to the anti–IL-17 agents.”
News
Expanded indications likely for apremilast
“My prediction is apremilast will have efficacy in children and teenagers comparable to what it has in adults.”
News
Merino wool clothing improves atopic dermatitis, studies find
In one study, the mean Eczema Area and Severity Index score in those initially randomized to merino wool improved from a mean baseline of 4.5 to 1...
News
Potential new option: 1-month DAPT post DES, then aspirin alone
The One-Month DAPT trial swapped aspirin monotherapy for prolonged P2Y12 inhibition.
News
Mitotic rate makes comeback as melanoma prognosticator
Key insight: the relationship between mitotic rate and melanoma survival is nonlinear.
News
Improvements in chronic hand eczema seen with oral gusacitinib in phase 2 study
The rapidity of response was noteworthy in these steroid-refractory patients.
News
Tildrakizumab for psoriasis shows durable efficacy over 5 years
Few left long-term extension study because of adverse events or loss of efficacy.
News
Inattention to heightened CV risk common theme in clozapine deaths teaser
“Inadequate treatment for metabolic syndrome was found to be a mortality predictor while on clozapine therapy,” said Dr. Sharon Taub.